HYPERION THERAPEUTICS INC 4
4 · HYPERION THERAPEUTICS INC · Filed May 8, 2015
Insider Transaction Report
Form 4
Salehizadeh Bijan
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07$46.00/sh−11,855$545,330→ 0 totalExercise: $4.08Exp: 2021-04-14→ Common Stock (11,855 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07$46.00/sh−9,800$450,800→ 0 totalExercise: $24.46Exp: 2023-04-14→ Common Stock (9,800 underlying) - Disposition to Issuer
Common Stock
2015-05-07$46.00/sh−2,617$120,382→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07$46.00/sh−4,105$188,830→ 0 totalExercise: $7.31Exp: 2022-04-15→ Common Stock (4,105 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-07$46.00/sh−4,869$223,974→ 0 totalExercise: $26.97Exp: 2024-05-26→ Common Stock (4,869 underlying)
Footnotes (2)
- [F1]Restricted stock units covering shares of issuer common stock that will be cashed-out and cancelled in connection with the merger of the issuer and Horizon Pharma plc (the "Merger").
- [F2]Options to acquire shares of issuer common stock that will be cashed-out and cancelled in connection with the Merger.